Rankings
▼
Calendar
FATE Q3 2022 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$142M
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$15M
+5.3% YoY
Gross Profit
-$65M
-432.8% margin
Operating Income
-$86M
-576.7% margin
Net Income
-$84M
-557.8% margin
EPS (Diluted)
$-0.83
QoQ Revenue Growth
-19.2%
Cash Flow
Operating Cash Flow
-$55M
Free Cash Flow
-$64M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$749M
Total Liabilities
$231M
Stockholders' Equity
$518M
Cash & Equivalents
$82M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$14M
+5.3%
Gross Profit
-$65M
-$39M
-66.7%
Operating Income
-$86M
-$55M
-58.2%
Net Income
-$84M
-$43M
-93.0%
Revenue Segments
Upfront Fee And Equity Premium
$4M
100%
← FY 2022
All Quarters
Q4 2022 →